Psychiatry and Mental Health

Episodes 1-11 of 11

CME/CE Meeting
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
July 30, 2025
Toronto
Learn more
Current and Emerging Treatments for PTSD in Women: An In-Depth Overview
Current and Emerging Treatments for PTSD in Women: An In-Depth Overview
CME/CE
Current and Emerging Treatments for PTSD in Women: An In-Depth Overview
0.25 credits
- Joseph F. Goldberg, MD
0.25 credits
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
CME/CE
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
0.25 credits
- Joseph F. Goldberg, MD
0.25 credits
Modeling Activity: Quality Conversations With Patients About Suboptimal Management of PTSD Symptoms and Emerging Treatment Options
Modeling Activity: Quality Conversations With Patients About Suboptimal Management of PTSD Symptoms and Emerging Treatment Options
MinuteCE®
Modeling Activity: Quality Conversations With Patients About Suboptimal Management of PTSD Symptoms and Emerging Treatment Options
1.00 program credit
- Roger McIntyre, MD
- Joseph F. Goldberg, MD
1.00 program credit
Pediatric Narcolepsy: Timely Diagnosis, Treatment, and Outcome Optimization
Pediatric Narcolepsy: Timely Diagnosis, Treatment, and Outcome Optimization
CME/CE
Pediatric Narcolepsy: Timely Diagnosis, Treatment, and Outcome Optimization
1.00 credit
- Anne Marie Morse, DO, FAASM
1.00 credit
D2 Antagonists Limitations and Challenges: A New Era in Schizophrenia Pathophysiology
D2 Antagonists Limitations and Challenges: A New Era in Schizophrenia Pathophysiology
MinuteCE®
D2 Antagonists Limitations and Challenges: A New Era in Schizophrenia Pathophysiology
1.25 program credits
- Leslie Citrome, MD, MPH
1.25 program credits
Exploring the Spectrum of Efficacy in Emerging Schizophrenia Therapies: From Positive to Negative to Cognitive Symptoms
Exploring the Spectrum of Efficacy in Emerging Schizophrenia Therapies: From Positive to Negative to Cognitive Symptoms
MinuteCE®
Exploring the Spectrum of Efficacy in Emerging Schizophrenia Therapies: From Positive to Negative to Cognitive Symptoms
1.25 program credits
- Christoph U. Correll, MD
1.25 program credits
Stratified Care: The Role of Switching or Augmentation Therapies Used When Treating Schizophrenia
Stratified Care: The Role of Switching or Augmentation Therapies Used When Treating Schizophrenia
MinuteCE®
Stratified Care: The Role of Switching or Augmentation Therapies Used When Treating Schizophrenia
1.25 program credits
- Leslie Citrome, MD, MPH
1.25 program credits
From Trial to Treatment: Translating Emerging Clinical Data into Meaningful Schizophrenia Clinical Care
From Trial to Treatment: Translating Emerging Clinical Data into Meaningful Schizophrenia Clinical Care
MinuteCE®
From Trial to Treatment: Translating Emerging Clinical Data into Meaningful Schizophrenia Clinical Care
1.25 program credits
- Christoph U. Correll, MD
1.25 program credits
Case Study: What Do Augmentation and Switching Strategies Look Like in Real-World Clinical Practice?
Case Study: What Do Augmentation and Switching Strategies Look Like in Real-World Clinical Practice?
MinuteCE®
Case Study: What Do Augmentation and Switching Strategies Look Like in Real-World Clinical Practice?
1.25 program credits
- Leslie Citrome, MD, MPH
1.25 program credits
MinuteCE®
Schizophrenia: Evidence-based Approaches to Integrating Emerging Treatments Into Clinical Practice
1.25 credits 5 episodes
- Leslie Citrome, MD, MPH
- Christoph U. Correll, MD
1.25 credits 5 episodes

Episodes 1-11 of 11

Title

Share on ReachMD